4//SEC Filing
MURDOCK TERRY L 4
Accession 0001562180-23-004099
CIK 0001560241other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:20 PM ET
Size
8.8 KB
Accession
0001562180-23-004099
Insider Transaction Report
Form 4
MURDOCK TERRY L
SVP of Development Operations
Transactions
- Award
Common Stock
2023-05-10+35,000→ 71,439 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on May 10, 2024 and 50% on May 10, 2025, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 4,039 shares of common stock; (ii) 5,500 RSUs from award granted on January 4, 2021; (iii) 9,000 RSUs from award granted on January 3, 2022; (iv) 17,900 RSUs from award granted on January 3, 2023, and (v) 35,000 RSUs from award granted on May 10, 2023.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001274071
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:20 PM ET
- Size
- 8.8 KB